Plasma exchange for treatment of thrombotic thrombocytopenic purpura in critically ill patients
Paul Knöbl(Medical University of Vienna), Michael Frass(Medical University of Vienna), Paul A. Kyrle(Karl Landsteiner Society), Sebastian Globits(Rudolfinerhaus Hospital), C Wiltschke(University of Vienna), Klaus Laczika(Austrian Atherosclerosis Society), I. Schwarzinger(University of Vienna), Gabriela Kornek(Medical University of Vienna), C. Rintelen(University of Vienna), P Kalhs(University of Vienna), Thomas Staudinger(Northwestern University)
Cited by 27
Related Papers
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
|The Lancet Infectious Diseases|2013|876
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Deep vein thrombosis
|The Lancet|2005|620